Thai Cancer Anemia Survey in Chulalongkorn Hospital

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Janssen-Cilag Ltd.,Thailand
ClinicalTrials.gov Identifier:
NCT01018043
First received: November 19, 2009
Last updated: May 22, 2014
Last verified: May 2014

November 19, 2009
May 22, 2014
April 2006
December 2009   (final data collection date for primary outcome measure)
Number of patients that have anemia during cancer therapy [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01018043 on ClinicalTrials.gov Archive Site
Characteristic of each patients example treatment duration,type and chemotherapy using, grade of anemia [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Thai Cancer Anemia Survey in Chulalongkorn Hospital
Thai Cancer Anemia Survey in Chulalongkorn Hospital

The purpose of this study is to create a large Thailand database documenting the severity of anemia and its management in the cancer population.

Thai Cancer Anemia Study (TCAS) is a prospective survey that will track anemia management in an adult cancer population. This survey is not intended to interfere with standard medical practices for handling anemia. Information on laboratory values including target and achieved hemoglobin (Hb) levels during chemotherapy cycles, use of blood transfusions, iron supplementation, and epoetin will be collected in addition to information on cancer status and treatment. Data on the level that triggers clinicians to decide on the need for anemia therapy will also be collected. Each patient included in the survey will be followed for six months. Observational Study - No investigational drug administered

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Anemic patients with cancer receiving chemotherapy

  • Anemia
  • Cancer
Other: Adult Cancer Patients
Tracking anemia management in Adult Cancer Patients
001
Adult Cancer Patients Tracking anemia management in Adult Cancer Patients
Intervention: Other: Adult Cancer Patients
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
264
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with cancer

Exclusion Criteria:

  • None
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Thailand
 
NCT01018043
CR011731, TCAS-CU-ONCO-2006
No
Janssen-Cilag Ltd.,Thailand
Janssen-Cilag Ltd.,Thailand
Not Provided
Study Director: Janssen-Cilag Ltd Clinical Trial Janssen-Cilag Ltd.
Janssen-Cilag Ltd.,Thailand
May 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP